Complex Partial Seizures Workup

  • Author: Elizabeth Carroll, DO; Chief Editor: Selim R Benbadis, MD   more...
 
Updated: Jun 16, 2011
 

Approach Considerations

Laboratory studies aim to rule out potential causes or triggers for seizures. These causes generally do not cause chronic epilepsy but may be triggers in patients with epilepsy. Routine workup for all patients should include electroencephalography (EEG) and magnetic resonance imaging (MRI) of the brain; most of the time, the results will be normal.

Workup after drug failure

A patient with seizures that are difficult to control should be reassessed for a possible alternative diagnoses or temporal lobe epilepsy. This is done with prolonged EEG-video monitoring to record patient events.

About 30% of patients thought to have complex partial seizures actually have psychogenic nonepileptic seizures. These events can be recorded and reviewed during monitoring. Recorded and confirmed cases of temporal lobe epilepsy via monitoring should be considered for possible surgery and undergo the remainder of the evaluation for surgery (eg, single-photon emission computed tomography [SPECT], positron emission tomography [PET]).

Next

Lab Studies

Electrolyte levels, including sodium, potassium, magnesium, and calcium concentrations, should be assessed. If antiepileptic drugs are being used, drug concentrations should be obtained. Consider a urine drug screen.

Previous
Next

Magnetic Resonance Imaging of Brain

The purpose of the initial brain MRI is to exclude an obvious structural lesion as the cause.[14, 15] The procedure should include contrast with gadolinium to allow assessment of possible neoplastic and vascular etiologies. More subtle etiologies, such as mesial temporal sclerosis (MTS) and cortical dysplasia, only become important if the seizures prove intractable and surgery is considered.

MRI with temporal cuts gives attention to hippocampal volumes in assessment for temporal lobe epilepsy. Hippocampal atrophy predominates as seizures are maintained throughout the life of a patient with temporal lobe epilepsy. Increased signal on fluid-attenuation inversion recovery (FLAIR) T2-weighted MRI can detect sclerosis of the mesial temporal lobe in 80-90% of cases. Subtle cortical changes due to cortical dysplasia are often overlooked.

Previous
Next

Electroencephalography

EEG within 24 hours is more sensitive for diagnosing epileptiform abnormalities than later EEG is (51% sensitivity vs 34%), but it is often impractical. When epileptiform discharges are present, they help localize the seizure focus (see the images below).

Left temporal sharp wave. Left temporal sharp wave. Left temporal lobe seizure. Left temporal lobe seizure.

A negative interictal EEG does not exclude a diagnosis of epilepsy. If the waking EEG is negative, a sleep-deprived EEG may demonstrate epileptiform abnormalities.

For more information, see EEG in Common Epilepsy Syndromes, EEG in Status Epilepticus, Epileptiform Normal Variants on EEG, Generalized Epilepsies on EEG, and Localization-Related Epilepsies on EEG.

Previous
Next

Lumbar Puncture

Lumbar puncture may be indicated for a patient with new-onset seizure when an acute inflammatory or infectious process is being considered. However, it is not indicated in patients with chronic epilepsy.

Previous
Proceed to Treatment & Management
 
 
Contributor Information and Disclosures
Author

Elizabeth Carroll, DO  Resident Physician, Department of Neurology, University of South Florida College of Medicine

Elizabeth Carroll, DO is a member of the following medical societies: American Academy of Neurology, American Osteopathic Association, and Florida Osteopathic Medical Association

Disclosure: Nothing to disclose.

Coauthor(s)

Selim R Benbadis, MD  Professor, Director of Comprehensive Epilepsy Program, Departments of Neurology and Neurosurgery, Tampa General Hospital, University of South Florida College of Medicine

Selim R Benbadis, MD is a member of the following medical societies: American Academy of Neurology, American Academy of Sleep Medicine, American Clinical Neurophysiology Society, American Epilepsy Society, and American Medical Association

Disclosure: UCB Pharma Honoraria Speaking, consulting; Lundbeck Honoraria Speaking, consulting; Cyberonics Honoraria Speaking, consulting; Glaxo Smith Kline Honoraria Speaking, consulting; Pfizer Honoraria Speaking, consulting; Sleepmed/DigiTrace Honoraria Speaking, consulting

Specialty Editor Board

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Chief Editor

Selim R Benbadis, MD  Professor, Director of Comprehensive Epilepsy Program, Departments of Neurology and Neurosurgery, Tampa General Hospital, University of South Florida College of Medicine

Selim R Benbadis, MD is a member of the following medical societies: American Academy of Neurology, American Academy of Sleep Medicine, American Clinical Neurophysiology Society, American Epilepsy Society, and American Medical Association

Disclosure: UCB Pharma Honoraria Speaking, consulting; Lundbeck Honoraria Speaking, consulting; Cyberonics Honoraria Speaking, consulting; Glaxo Smith Kline Honoraria Speaking, consulting; Pfizer Honoraria Speaking, consulting; Sleepmed/DigiTrace Honoraria Speaking, consulting

References

  1. Lee KH, Meador KJ, Park YD, et al. Pathophysiology of altered consciousness during seizures: subtraction SPECT study. Neurology. 2002;59(6):841-6. [Medline].

  2. Cascino GD. Temporal Lobe Epilepsy is a progressive Neurologic Disorder: time means Neurons!. Neurology. 2009;72:1718-1719. [Medline].

  3. Rocca WA, Sharbrough FW, Hauser WA, et al. Risk factors for complex partial seizures: a population-based case-control study. Ann Neurol. Jan 1987;21(1):22-31. [Medline].

  4. Annegers JF. The epidemiology of epilepsy. In: Wyllie E, ed. The Treatment of Epilepsy: Principles and Practice. Baltimore, Md: Williams & Wilkins; 1997:165-2.

  5. Cockerell OC. The mortality of epilepsy. Curr Opin Neurol. 1996;9(2):93-6. [Medline].

  6. Leestma JE, Walczak T, Hughes JR, et al. A prospective study on sudden unexpected death in epilepsy. Ann Neurol. 1989;26(2):195-203. [Medline].

  7. Luders H, Acharya J, Baugmgartner C, Benbadis S et al. Semiological seizure classification. Epilepsia. Sept 1998;39 (9):1006-13. [Medline].

  8. Noachtar S, Peters AS. Semiology of epileptic seizures: a critical review. Epilepsy Behavior. Mary 2009;15(1):2-9. [Medline].

  9. Pazzaglia P, D'Alessandro R, Lozito A, Lugaresi E. Classification of partial epilepsies according to the symptomatology of seizures: practical value and prognostic implications. Epilepsia. Jun 1982;23(3):343-50. [Medline].

  10. Janszky J, Foqarasi A, Mafalova V. Unilateral hand automatisms in temporal lobe epilepsy. Seizure. 2006;15(6):393-396. [Medline].

  11. Kotagal P, Arunkumar G, Hammel J, Mascha E. Complex partial seizures of frontal lobe onset statistical analysis of ictal semiology. Seizure. 2003;12(5):268-81. [Medline].

  12. Loddenkemper T, Kotagal P. Lateralizing sings during seizures in focal epilepsy. Epilepsy and Behavior. 2005;7:1-17. [Medline].

  13. Horvath R, Kalmar Z, Feher N, Fogarasi A, Gyimesi C, Janszky J. Brain lateralization and seizure semiology: ictal clinical lateralizing signs. Ideggyogy Sz. Jully 2008;61 (7-8):231-237. [Medline].

  14. King MA, Newton MR, Jackson GD, et al. Epileptology of the first-seizure presentation: a clinical, electroencephalographic, and magnetic resonance imaging study of 300 consecutive patients. Lancet. 1998;352(9133):1007-11. [Medline].

  15. Knake S, Triantafyllou C, Wald LL, et al. 3T phased array MRI improves the presurgical evaluation in focal epilepsies: a prospective study. Neurology. 2005;65(7):1026-1031. [Medline].

  16. Arunkumar G, Morris H. Epilepsy update: new medical and surgical treatment options. Cleve Clin J Med. 1998;65(10):527-32, 534-7. [Medline].

  17. Browne TR. Pharmacokinetics of antiepileptic drugs. Neurology. 1998;51(5 suppl 4):S2-7. [Medline].

  18. Consensus Committee. Consensus statements: medical management of epilepsy. Neurology. 1998;51(5 suppl 4):S39-43. [Medline].

  19. Feely M. Fortnightly review: drug treatment of epilepsy. BMJ. 1999;318(7176):106-9. [Medline].

  20. French J, Smith M, Faught E, Brown L. Practice advisory: The use of felbamate in the treatment of patients with intractable epilepsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. May 12 1999;52(8):1540-5. [Medline].

  21. French JA, Pedley TA. Clinical practice. Initial management of epilepsy. N Engl J Med. Jul 10 2008;359(2):166-76. [Medline].

  22. Koepp MJ, Woermann FG. Imaging structure and function in refractory focal epilepsy. Lancet Neurol. 2005;4(1):42-53. [Medline].

  23. Levy RH, Mattson RH, Meldrum BS. Antiepileptic Drugs. 4th ed. New York, NY: Raven; 1995.

  24. Mattson RH. Medical management of epilepsy in adults. Neurology. 1998;51(5 suppl 4):S15-20. [Medline].

  25. Pellock JM. Treatment of seizures and epilepsy in children and adolescents. Neurology. 1998;51(5 Suppl 4):S8-14. [Medline].

  26. Schlienger RG, Shear NH. Antiepileptic drug hypersensitivity syndrome. Epilepsia. 1998;39(suppl 7):S3-7. [Medline].

  27. Artama M, Auvinen A, Raudaskoski T, et al. Antiepileptic drug use of women with epilepsy and congenital malformations in offspring. Neurology. 2005;64(11):1874-8. [Medline].

  28. Harden CL, Pennell PB, Hauser WA. Practice Parameter Update: Management Issues for women with epilepsy - focus on pregnancy (an evidence-based review): Vitamin K, folic acid, blood levels, and breastfeeding. Neurology. July 2009;73 (2):142-149. [Medline].

  29. Meador KJ, Baker GA, Finnell RH, et al. In utero antiepileptic drug exposure: fetal death and malformations. Neurology. Aug 8 2006;67(3):407-12. [Medline].

  30. Morrell MJ. Guidelines for the care of women with epilepsy. Neurology. 1998;51(5 suppl 4):S21-7. [Medline].

  31. Pellock JM, Willmore LJ. A rational guide to routine blood monitoring in patients receiving antiepileptic drugs [editorial]. Neurology. Jul 1991;41(7):961-4. [Medline].

  32. American Academy of Neurology. Practice parameter: a guideline for discontinuing antiepileptic drugs in seizure-free patients--summary statement. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. Aug 1996;47(2):600-2. [Medline].

  33. Benbadis SR. Epileptic Seizures and Syndromes. Neurologic Clinics. May 2001;19 (2):[Medline].

  34. Benbadis SR, Tatum WO. Advances in the Treatment of Epilepsy. American Family Physician. July 2001;64 (1):91-98. [Medline].

 
Previous
Next
 
Note oral and hand automatisms at initiation of event. Patient is not following commands or answering questions during the event.
Left temporal sharp wave.
Left temporal lobe seizure.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.